Oncology & Cancer

Breaking the link between obesity, gastrointestinal cancers

Studies have demonstrated a connection between obesity and a person's risk of developing colon and other gastrointestinal cancers. Now, scientists are investigating approaches that can break this relationship.

Oncology & Cancer

Rewriting our understanding of gastric tumors

The immune system can be an important ally in the fight against cancer. A study from McGill scientists published today in Science suggests that the reverse may also be true—that abnormal inflammation triggered by the immune ...

Oncology & Cancer

Artificial intelligence helps to pinpoint roots of gastric cancer

In a pioneering study, scientists at A*STAR's Genome Institute of Singapore (GIS) have developed new machine learning computer models, a type of artificial intelligence (AI), to accurately pinpoint cancer mutations. They ...

Oncology & Cancer

Structural studies help explain how cancer cells resist chemotherapy

In order to kill cancer cells, chemotherapy drugs must first make their way inside them. But cancer cells are shrewd, and some use molecular pumps to expel the drugs before they have a chance to work. New research from Rockefeller's ...

Oncology & Cancer

Kinase inhibitor larotrectinib shows durable anti-tumor abilities

Three simultaneous safety and efficacy studies of the drug larotrectinib reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses. All patients had tumors ...

Oncology & Cancer

New drug approved for all cancers with genetic marker

(HealthDay)—Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat any cancer that has a certain genetic biomarker, regardless of where in the body the cancer originated.

page 6 from 19